Navigation Links
PCAN Calls On Federal Government to Reconsider Preliminary Approval of Texas' Medicaid Waiver Request
Date:9/19/2011

DALLAS, Sept. 19, 2011 /PRNewswire/ -- Pharmacy Choice and Access Now (PCAN) - a coalition of consumers, local businesses and pharmacists across the nation and Texas committed to preserving quality and affordable health care - today called on the Centers for Medicare and Medicaid Services (CMS) to reconsider their preliminary approval of Texas' waiver implementing a new Medicaid managed care plan switching pharmacy, among other health care services, to a managed-care model.

PCAN believes the Centers for Medicare and Medicaid Services (CMS) should reject the State of Texas' proposed Section 1115 waiver now pending before the agency, citing a precipitous decline in reimbursement rates that will force pharmacies out of business, as well as threaten patient services and access to care.

"The State's proposed implementation of managed care pharmacy services will devastate pharmacies in the state, kill jobs and hurt the quality of patient care for the most vulnerable among us.  It must be stopped in its tracks," said Tammy Gray, RPh, owner of a pharmacy in Buda and spokesperson for the Pharmacy Choice and Access Now (PCAN) coalition in Texas.

According to the group, the proposed implementation of the managed care model will drastically reduce reimbursement rates for local pharmacies that fill prescriptions and could force some out of business altogether and even more out of the Texas Medicaid program.  Currently, pharmacies receive reimbursement for Medicaid prescriptions through the Vendor Drug Program regulated by the state and open to all pharmacies.  Under the new plan, they will be subject to rates set by pharmacy benefits managers (PBMs) and managed care organizations, for-profit firms that will administer the managed care pharmacy program.

Independent pharmacies across Texas have already begun receiving contracts from at least one PBM that represents an 80 percent reduction in reimbursement rates per prescription dispensed or Medicaid patients.  Such drastic cuts are unsustainable for many pharmacies, particularly those in underserved rural and urban areas where prescription volume is heavily geared toward Medicaid recipients.

According to a study conducted for PCAN by The Perryman Group, proposed reimbursement cuts and the move to managed care would lead to the closure of hundreds of pharmacies, the loss of thousands of jobs and the elimination of access to pharmacies in many areas, both for the general population and for those receiving Medicaid.  The Perryman Group estimated nearly 43,000 job losses, 770 pharmacy closures and a $3.1 billion loss to the economy from the move to managed care for pharmacy.

PCAN further stressed that the managed care model is inappropriate for many segments of the Medicaid population, including the blind and disabled, who rely heavily on special services and counseling provided by pharmacists in addition to prescriptions.

"All Texans should be concerned about what's at stake here: quality health care, access to their local pharmacy and jobs in their community," concluded Gray.

Gray urged local pharmacists and concerned citizens to sign the Texas Pharmacy Protection Petition at www.rxchoiceandaccess.com.

About PCAN

Pharmacy Choice and Access Now (PCAN) is a coalition of consumers, local business and pharmacists across the nation committed to preserving quality and affordable health care and pharmacy services for patients.  We are committed to providing the most cost-effective solutions in the areas of health care and pharmacy services to enable states around the country to help solve their budget woes, while maintaining quality care for children, families and other Medicaid-served populations.

For more information on Pharmacy Choice and Access Now (PCAN), visit www.rxchoiceandaccess.com.


'/>"/>
SOURCE Pharmacy Choice and Access Now (PCAN)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mainor Eglet Attorney, Robert Eglet, Calls Teva Pharmaceuticals Vice President Craig Lea to the Stand in Hepatitis C Trial
2. Independent Expert Panel Calls for Information on Fragrance Ingredients Under Review
3. AVAC Says Results of New PrEP Trials Provide Clear Evidence that Antiretroviral Drugs for Prevention Can Help End the AIDS Epidemic; Calls for Quick Action to Move Landmark HIV Prevention Results Toward Lifesaving Programs
4. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
5. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
6. Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX®
7. Lilly CEO Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation
8. Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations
9. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
10. International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women
11. American Society of Tropical Medicine and Hygiene (ASTMH) Calls for Stronger FDA Science Investment to Better Fight Diseases of Poverty Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016 /PRNewswire/ - Demers Ambulances announces its ... to Okaloosa County Emergency Medical ... III ambulances and one LT2 van. Quality Emergency Vehicles in ... is responsible for the sale.  This is the latest in ... , Executive Vice President at Demers. --> Benoit ...
(Date:2/12/2016)... VIEJO , Kalifornien, 12. Februar 2016 /PRNewswire/ ... mit der Aufnahme von Patienten für eine Studie ... von Aneurysmen („WEB") speziell für die Behandlung von ... Spelle , MD, Leiter der Neuroradiologie an der ... Frankreich, und Hauptprüfarzt der CLARYS-Studie hat den ersten ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, ... Inc. today announced they will form a partnership ... precision medicine in cancer. The goal of the ... technology with Macrogen,s high-throughput Next Generation Sequencing capabilities ... Clinical Laboratory Improvement Amendments (CLIA) of 1988 by ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug Development: ... EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products are ... attention from all stakeholders in the development of new chemical entities. , However, ...
(Date:2/12/2016)... ... , ... Coco Libre, the maker of coconut water beverages with a purpose, ... Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, ... gifting suite, held this year at the W Hollywood Hotel, has become a pre-show ...
(Date:2/12/2016)... ... 12, 2016 , ... Itopia, a leader in cloud services ... Intelligence Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration engine. This ... small and medium business (SMB) clients. , In recent years, BI ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... ... 12, 2016 , ... Erlanger Agency has announced a new partnership in its ... campaign focuses on the fight against breast cancer, fundraising for a local woman named ... . , Carmen is a loving single mother of two boys who also serves ...
Breaking Medicine News(10 mins):